Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-23.96	22.69	29.84
Graham Fair Price	-8.20	63.82	69.52
PEG	-21.30	-0.87	1.11
Price/Book	5.02	1.73	1.65
Price/Cash Flow	-93.17	10.84	-158.76
Prices/Earnings	26.22	14.48	11.47
Price/Sales	-12.86	12.35	14.18
Price/FCF	-93.17	10.84	-158.76
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	14.19	1.23	1.07
ROA	-17.76	< 0.005	< 0.005
ROE	0.04	0.03	-16.80
ROIC	< 0.005	< 0.005	1.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.15	-94.61
Dividends QOQ	0.05	< 0.005	-81.45
EBIT QOQ	0.43	0.37	-14.20
EPS QOQ	0.10	-0.17	60.38
FCF QOQ	-1.09	16.32	1398.34
Revenue QOQ	0.12	0.20	73.15
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	763.55	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.80	0.80	0.24
Quick Ratio	1.67	2.89	72.97
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	77.39	77.89	0.64
Cash	172.30	258.50	50.03
Capex	-0.55	-0.50	8.58
Free Cash Flow	-0.80	12.41	1447.33
Revenue	8.98	10.89	21.29
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.67	2.89	72.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.29	12.99	-24.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating